Cavalier Investments’s Albemarle ALB Stock Holding History

Cavalier Investments’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,160	Closed	-$3.26M	–	72
2026 Q1	$3.26M	Buy	+18,160	New	+$3.1M	0.09%	76

Other funds holding ALB

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Cavalier Investments's ALB Position: Q2 2026 in Review

Cavalier Investments sold out of Albemarle (ALB) in Q2 2026, closing a stake of 18,160 shares — an estimated $3.26M sold.

Cavalier Investments first reported a position in ALB in Q1 2026 and held it in 1 quarter. The position peaked at $3.26M in Q1 2026. 945 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

Cavalier Investments reported no remaining Albemarle position as of Q2 2026 after selling out during the quarter.
Cavalier Investments sold 18,160 Albemarle shares in Q2 2026, an estimated $3.26M.
Cavalier Investments first reported a position in Albemarle in Q1 2026 and held it in 1 quarter.
Cavalier Investments's Albemarle position peaked at $3.26M in Q1 2026.
945 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Cavalier Investments's 13F filing for Q2 2026, filed 14 Aug 2026.